Rentokil Initial (NYSE:RTO) Rating Increased to Buy at Wall Street Zen

Rentokil Initial (NYSE:RTOGet Free Report) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

Other equities analysts have also issued research reports about the stock. Zacks Research lowered shares of Rentokil Initial from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 4th. Weiss Ratings restated a “hold (c-)” rating on shares of Rentokil Initial in a research report on Thursday, January 22nd. Bank of America raised shares of Rentokil Initial from a “neutral” rating to a “buy” rating and set a $34.00 target price for the company in a research note on Thursday, December 18th. Oppenheimer boosted their price target on Rentokil Initial from $30.00 to $35.00 and gave the company an “outperform” rating in a report on Tuesday, March 10th. Finally, Morgan Stanley upgraded Rentokil Initial from an “equal weight” rating to an “overweight” rating in a report on Tuesday, January 6th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, Rentokil Initial has an average rating of “Moderate Buy” and a consensus price target of $34.50.

Get Our Latest Report on RTO

Rentokil Initial Stock Down 0.5%

NYSE:RTO opened at $30.57 on Friday. Rentokil Initial has a 12-month low of $19.60 and a 12-month high of $33.47. The company’s 50-day moving average is $31.59 and its two-hundred day moving average is $29.05. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.03 and a current ratio of 1.12.

Hedge Funds Weigh In On Rentokil Initial

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Pullen Investment Management LLC increased its position in Rentokil Initial by 0.7% during the third quarter. Pullen Investment Management LLC now owns 48,758 shares of the company’s stock worth $1,231,000 after purchasing an additional 359 shares during the last quarter. Vestmark Advisory Solutions Inc. grew its stake in shares of Rentokil Initial by 2.0% during the 3rd quarter. Vestmark Advisory Solutions Inc. now owns 21,228 shares of the company’s stock valued at $536,000 after buying an additional 414 shares during the period. Evergreen Capital Management LLC increased its holdings in shares of Rentokil Initial by 5.4% during the 4th quarter. Evergreen Capital Management LLC now owns 10,425 shares of the company’s stock worth $307,000 after buying an additional 531 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Rentokil Initial by 76.5% during the 4th quarter. GAMMA Investing LLC now owns 1,232 shares of the company’s stock worth $36,000 after buying an additional 534 shares during the last quarter. Finally, Patriot Financial Group Insurance Agency LLC increased its holdings in shares of Rentokil Initial by 2.6% during the 4th quarter. Patriot Financial Group Insurance Agency LLC now owns 24,151 shares of the company’s stock worth $711,000 after buying an additional 619 shares during the last quarter. Institutional investors and hedge funds own 9.91% of the company’s stock.

Rentokil Initial Company Profile

(Get Free Report)

Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.

Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.

Further Reading

Analyst Recommendations for Rentokil Initial (NYSE:RTO)

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.